Made available in DSpace on 2015-04-22T22:06:44Z (GMT). No. of bitstreams: 1 ALEX_GONCALVES.pdf: 1200334 bytes, checksum: d88f52a9c61abd36247626ef3528ba98 (MD5) Previous issue date: 2011-02-28 / CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / The EEEV and WEEV are Arboviruses of the family Togaviridae, genus Alphavirus, which measure 60-70 nm in diameter and is composed of transmembrane glycoproteins E1 and E2, the capsid protein or the nucleocapsid, which is derived from the lipid bilayer of the host, and a single molecule single-stranded RNA and positive polarity. They are transmitted by mosquitoes, primarily Culex, Aedes, whose natural reservoir of birds and humans as accidental hosts, horses and other small mammals. Infected individuals are asymptomatic or develop flu-like illness that may progress to severe neurological disease with a prevalence in humans in North America and horses across America. The fatality rate for EEE in humans is 30% and 40% for WEE is 10%. The study was observational, cross-sectional analytical study carried out in individuals of both sex, aged over 18, resident of the lake Tucuruí power plant and from the RDS and Alcobaça Pucurui-Ararão. The collection of blood samples and filling in the questionnaire were performed at two different times, in September/2008 and March/2009. All samples were analyzed by the Evandro Chagas Institute where they were tested with hemagglutination inhibition for detection of antibodies against 19 types of Arboviruses. Data analysis was descriptive and analytical, and used the chi-square or Fisher exact test to verify the statistical significance of associations between variables of the study with an alpha level of 0,05. Altogether 365 samples were analyzed, which showed 1.1% positive for EEE and 1.6% for WEE. Most positive cases had poor sanitary conditions (100% for EEA and 83.3% for WEE) using cesspits (75% to 100% for EEE and WEE) and water from rivers and / or lakes ( 100% to 83.3% for EEE and WEE). The positive cases for EEE and WEE were related to other Arboviruses, where 100% of EEE and WEE were positive for HI-Flavivirus, 25% for EEE virus Maguari, HI-Mayaro and HI-Oropouche and 33.3 % of WEE to HI-Mayaro and 16.7% for the virus Guaroa. The study confirmed the presence of EEE virus and WEE in the region and some socio-environmental factors such as use of cesspits and poor sanitation conditions, conducive to public exposure to vectors and raised the possibility of cross protection with other alphaviruses. / O EEEV e o WEEV são Arbovírus da família Togaviridae, gênero Alphavirus, que medem 60 a 70 nm de diâmetro e é composto por glicoproteínas transmembrana E1 e E2, o capsídio ou proteína do nucleocapsídio, que deriva da bicamada lipídica do hospedeiro, e uma única molécula de RNA de fita única e de polaridade positiva. São transmitidos por mosquitos, principalmente Culex e Aedes, tendo como reservatório natural os pássaros e como hospedeiros acidentais os humanos, equinos e outros pequenos mamíferos. Os indivíduos infectados são assintomáticos ou desenvolvem síndrome gripal que podem evoluir para doença neurológica graves com predominância em humanos na América do Norte e em equinos em toda América. A taxa de letalidade em humanos para EEE é de 30% a 40% e para WEE é de 10%. O estudo foi observacional do tipo transversal analítico, realizado em indivíduos de ambos os sexos, maiores de 18 anos, residentes do lago UHE de Tucuruí e proveniente das RDS de Alcobaça e Pucuruí-Ararão. A coleta das amostras de sangue e o preenchimento do questionário foram realizados em dois momentos distintos, em setembro/2008 e março/2009. Todas as amostras foram analisadas pelo Instituto Evandro Chagas onde foram submetidas ao teste de Inibição da Hemaglutinação para a pesquisa de anticorpos contra 19 tipos de Arbovírus. A análise dos dados foi descritiva e analítica, sendo empregado o teste qui-quadrado e/ou exato de Fisher a fim de verificar a significância das associações estatísticas entre as variáveis do estudo com um nível alfa de 0,05. Ao todo foram analisadas 365 amostras, que mostraram positividade de 1,1% para EEE e de 1,6% para WEE. A maioria dos casos positivos tinha condições de saneamento ruim (100% para EEE e 83,3% para WEE), com uso fossa negra (75% para EEE e 100% para WEE) e abastecimento de água de rios e/ou lagos (100% para EEE e 83,3% para WEE). Os casos positivos para EEE e WEE tiveram relação com outros Arbovírus, sendo que 100% de EEE e WEE eram positivos para HI-Flavivírus, 25% de EEE para o vírus Maguari, HI-Mayaro e HI-Oropouche e 33,3% de WEE para HI-Mayaro e 16,7% para o vírus Guaroa. O estudo confirmou a presença dos vírus da EEE e WEE na região e que alguns fatores sócio-ambientais, como uso de fossa negra e condições de saneamento ruins, favorecem a exposição da população aos vetores e levantou a hipótese de proteção cruzada com outros Alphavírus.

Thesis (Dr. P.H.)--University of Texas School of Public Health, 2008. Thesis (Dr. P.H.)--University of Texas Health Science Center at Houston, School of Public Health, 2008. / Source: Dissertation Abstracts International, Volume: 69-02, Section: B, page: 0973. Adviser: Kristy O. Murray. Includes bibliographical references.

The proposed thesis contributes to the basic knowledge in tick (Ixodes ricinus) and tick-borne pathogens (Borrelia burgdorferi sensu lato, tick-borne encephalitis virus) ecology in particular studying the spatial distribution, host associations and its causes and consequences in Central European habitats.

Japanese encephalitis virus (JEV) and West Nile virus (WNV) are closely related Flaviviruses that are important arthropod-borne human pathogens. Both of these viruses can cause encephalitis with significant morbidity and mortality after infection. Flaviviruses co-circulate in many areas of the world, which raises the risk for sequential infection between heterologous viruses. Sequential infection between dengue virus serotypes can lead to cross-protection, but in some cases, it leads to a severe outcome, dengue hemorrhagic fever. Previous work in hamsters and non-human primates demonstrated that prior JEV immunity protects against a lethal WNV infection. However, the ability of prior WNV immunity to protect against a lethal JEV infection has been inconclusive. WNV-immune hamsters were fully protected from JEV viremia, but in non-human primates, prior WNV-immunity only reduced disease severity, with symptoms of encephalitis still observed. These differences in cross-protection led to further investigation on the directionality as well as the underlying mechanisms for this phenomenon. Previous work in our lab found that JEV-immune C57BL/6J (B6) mice were fully protected against a lethal WNV infection, and JEV-immune CD4+ and CD8+ T cells were required for this cross-protection. In other mouse models, memory cross-reactive CD4+ and CD8+ T cell responses may induce protection or immunopathology upon secondary heterologous viral challenge. We hypothesize that JEV/WNV cross-reactive CD4+and CD8+ T cells preferentially expand upon 2o infection and contribute to cross-protection. To elucidate the potential role of T cells in sequential flavivirus infection, we identified and characterized cross-reactive CD4+ and CD8+ T cell responses between JEV and WNV. A previously reported WNV NS4b CD8+ T cell epitope and its JEV variant elicited CD8+ T cell responses in both JEV- and WNV-infected mice. Despite similarities in viral burden for pathogenic JEV and WNV viruses, CD8+ T cells from pathogenic JEV-infected mice exhibited functional and phenotypic profiles similar to those seen for the attenuated JEV strain. We believe the differences in the CD8+ T cell responses during primary JEV and WNV infection are due at least in part to the low levels of peripheral replication seen in JEV-infected mice compared to WNV-infected mice. We also found that WNV-immune B6 mice were protected against a lethal JEV infection. Cross-reactive CD8+ T cells in JEV-immune mice rapidly expanded after WNV infection. Even though WNV-immune mice had higher frequencies of memory CD8+ T cells, cross-reactive CD8+ T cells did not expand after secondary JEV infection. Neutralizing antibodies to JEV were detected in WNV-immune mice; however, cross-reactive CD8+ T cells did not expand even in the absence of these cross-reactive neutralizing antibodies. We did not detect any differences in the CD8+ T cell repertoires between JEV- and WNV-infected mice nor were WNV-immune CD8+ T cells functionally exhausted. In fact, proliferation of memory CD8+ T cells did not correlate with the ability of WNV-immune CD8+ T cells to restrict recombinant vaccinia viruses expressing the cross-reactive epitope or lyse peptide-coated targets. These data suggest that the higher frequency of memory CD8+ T cells and cross-reactive antibodies in WNV-immune mice are better able to prevent neuroinvasion following 2o JEV infection.

Venezuelan equine encephalitis virus (VEEV) is an alphavirus that causes disease in humans and equines eliciting both an agricultural and public health threat. In humans, the disease typically presents as a febrile illness with common signs of fever and malaise. Four to fourteen percent of Venezuelan equine encephalitis (VEE) cases are associated with severe neurological complications due to encephalitis caused by VEEV's propensity to infect the brain. Public health concerns are exacerbated by VEEV's aerosolization capabilities, low infectious dose and affordability to mass produce. These qualities drove interest in the pathogen as a bioweapon by the US and the former Soviet Union during the cold war. As a precautionary response to VEEV's notoriety as a biothreat, the National Institute of Allergies and Infectious Diseases has classified VEEV as a category B priority pathogen, and the Human Health Services and United States Department of Agriculture list live virulent strains of VEEV as a select agent and require the pathogen to be manipulated in highly regulated biosafety level 3 (BSL3) facilities. There are currently no FDA approved vaccines or antivirals to target VEEV or other closely related alphaviruses associated with clinical disease in humans. The research performed in this dissertation aimed to elucidate new antiviral targets and treatments to help bridge gaps in current understanding of alphaviruses. The current market lacks available antibodies for E1 specific isolation. In response, a recombinant VEEV TC-83 was produced with a V5 tag at the C-terminal of the E1 sequence to enable VEEV E1 detection. Sequencing was used to verify V5 insertion in the plasmid and immunoprecipitation was used to verify V5 insertion within the E1 glycoprotein. Replication kinetics experiments verified the virus replicated similarly to the parental VEEV TC-83 strain, while passaging experiments verified the tag was highly stable for up to 10 passages. This research produced a cost-effective and highly efficient means to probe and isolate the E1 glycoprotein without modifying the viability of the virus. Knowledge of host protein interactions with VEEV E1 glycoprotein has been limited, with most E1 research focusing on its fusion capabilities. Utilizing 293-T cells infected with E1-V5 TC-83, co-immunoprecipitation was performed to isolate E1 and associated interactors. A total of 486 host and 5 viral protein interactors of E1 were discovered after normalization to the negative control. The top peptide spectrum matches (PSMs) revealed a number of chaperone proteins and ubiquitin proteins as top interactors of VEEV E1. These results effectively revealed a number of previously unknown alphavirus interactions that can be targeted by antivirals and explored further for implications in viral replication. LC-MS/MS results showed that protein disulfide isomerase family A member 6 (PDIA6) interacted with E1. High PSMs, presence in all 3 replicates, similar cellular localization to E1 and known associations between other viruses and protein disulfide isomerase (PDI) family members made this protein an optimum target for further analysis. Co-immunoprecipitation and co-localization experiments were used to validate the LC-MS/MS results. Involvement of PDIs in VEEV replication were explored utilizing two known PDI inhibitors, LOC14 and Nitazoxanide. LOC14, a non-FDA approved broad-spectrum PDI inhibitor, showed broad-spectrum alphavirus antiviral potential, decreasing titers of VEEV TC-83, VEEV Trinidad Donkey strain, eastern equine encephalitis virus (EEEV), chikungunya virus (CHIKV) and Sindbis (SINV) virus in a dose dependent manner. Nitazoxanide, an FDA approved drug known to inhibit PDIA3, was shown to have minimal toxicity and effectively reduced VEEV TC-83 and EEEV titers at concentrations with 100% cell viability. Time of addition assays, E1 expression time course studies, and early event assays showed PDI inhibition with these drugs effects early viral production events. RNA quantification, confocal microscopy and biotin switch assay experiments show that the drugs also prevented proper folding of the E1 glycoprotein and decreased expression of E1 on the peripheral membrane. With no current treatments for alphaviruses, these data provide an effective broad-spectrum target that affects viral replication at multiple stages in-vitro. Nitazoxanide also presents as a promising, non-toxic drug that could be repurposed to combat a number of clinically relevant alphaviruses. Valosin containing protein (VCP) was also shown to interact with the E1 glycoprotein. Exploration of VCP's interaction with alphavirus E1 has never been explored, yet it was previously shown to be involved in alphavirus replication. Co-localization and co-immunoprecipitation experiments were performed validating the interaction between VCP and E1. siRNA knockdown of VCP in 293-T cells and U87-MG cells showed a significant reduction in VEEV TC-83 titers. The allosteric VCP inhibitor, NMS-873, also reduced VEEV TC-83 titers, but was shown to be less effective against CHIKV, SINV and EEEV, suggesting the NMS-873 mechanism is more selective for VEEV. Mechanism experiments showed that reduction of VCP with NMS-873 inhibits early events of VEEV replication. These results elucidate VCP's association with E1 and show that VCP can be targeted to decrease VEEV viral replication. / Doctor of Philosophy / Venezuelan equine encephalitis virus (VEEV) causes disease in humans, as well as horses, donkeys and other closely related animals. In humans, the virus causes a flu-like disease and sometimes swelling of the brain. This can be associated with symptoms such as light sensitivity, confusion and sometimes coma. Prior to the Cold War, VEEV was researched by the US and previous Soviet Union's militaries in hopes to deploy the virus as a bioweapon. Current treaties prevent active production of such weapons, yet allows for defensive research to continue in preparation for a worst-case scenario. Currently no FDA approved medications or vaccines exist to combat the virus further exacerbating concerns. In order to protect laboratorians and prevent unintentional or intentional introduction of the virus into the community, the virus is only manipulated in highly secure facilities with barriers that separate the virus from personnel and the outside environment. A component of the virus called E1, allows for the virus to be released from a structure, called an endosome, that transports the virus into the cell. Currently, E1 is mostly known for this function, yet our research found that E1 interacts with 486 protein components of the host cell, suggesting a more elaborate role of E1 than previously understood. This list of interactors provides numerous new targets for potential medications to combat VEEV and other closely related viruses. Discovered E1 interactors, protein disulfide isomerase family A member 6 (PDIA6) and valosin containing protein (VCP), were validated through extensive experimentation and their function in viral replication was further explored. Protein disulfide isomerases (PDI), such as PDIA6, play an important role in folding proteins, which are cellular components made of organic building blocks called amino acids. PDIs do so by creating organic pillars, called disulfide bonds, between two cysteine amino acid residues. These disulfide bonds contribute to the 3D shape of the proteins they fold which are essential for the protein's function. E1 of VEEV has a total of eight disulfide bonds within its structure, highlighting that disulfide bonds are likely essential for the protein's structure, and therefore, function. We verified that E1 could not properly fold without PDI function by using two compounds that prevented PDI from forming or breaking disulfide bonds, specifically LOC14 and FDA approved drug nitazoxanide. Cells treated with one of either compound before and after infection with VEEV, were found to produce E1 protein with significantly less disulfide bonds therefore producing less viable virus. Further experiments also showed that the compounds also affected early stages in the virus production cycle. These two mechanisms explain the significant reduction in production of VEEV and related viruses when PDI is inhibited. These results provide a new VEEV drug target, PDIs, as well as two compounds that can potentially be used to combat VEEV and other related viruses that have no current treatment options. Another host interactor, VCP, functions throughout the cell and is known for unfolding of numerous substrates, including proteins. It is involved in numerous cellular functions thus making this interactor a promising target for drug treatment. Cells with reduced VCP function were shown to produce less progeny VEEV. Cells treated with NMS-873, a compound that reduces VCP function was also shown to reduce VEEV production. NMS-863 inhibition of VCP was shown to effect early events in VEEV replication. These results further emphasize the E1 interactors discovered are invaluable novel targets for VEEV drug treatment.

Ticks are important vectors of a wide variety of pathogens including protozoa, bacteria and viruses. Many of the viruses transmitted by ticks are of medical or veterinary importance including tick-borne encephalitis virus (TBEV) and Crimean- Congo hemorrhagic fever virus causing disease in humans, and African swine fever virus and Nairobi sheep disease virus affecting livestock. Although several studies have elucidated tick antimicrobial mechanisms including cellular immune responses such as nodulation, encapsulation and phagocytosis and humoral immune responses such as the JAK/STAT pathway, complement-like proteins, antimicrobial peptides, lectin like pattern-recognition molecules and lysozymes, very little is known about the innate immune response of ticks towards viral infection. This study therefore aimed to identify molecules that might be involved in the response of ticks to viral infection. The hypothesis was that TBEV infection leads to changes in the expression of immunity-related transcripts and proteins in Ixodes spp. tick cells and that at least some of these might be antiviral. Ixodes scapularis-derived cell lines IDE8 and ISE6 were chosen since I. scapularis is currently the only tick species with a sequenced genome and an Ixodes ricinus-derived cell line, IRE/CTVM19, was used because I. ricinus is the natural vector of TBEV. Basic parameters required to study the responses of tick cells to infection were determined, including levels of virus infection, kinetics of virus replication and production, formation of replication complexes and uptake of dsRNA or siRNA. The cell lines IDE8, ISE6 and IRE/CTVM19 were infected with either of two tick-borne flaviviruses, TBEV and Langat virus (LGTV), or with the mosquito-borne alphavirus Semliki Forest virus (SFV). Infection was characterised using techniques including plaque assay, luciferase assay, immunostaining and conventional, confocal and electron microscopy. Two time points for transcriptomics and proteomics analysis of TBEVinfected IDE8 and IRE/CTVM19 cells were selected: day 2 post-infection (p.i.) when virus production was increasing and day 6 p.i. when virus production was decreasing. RNA and protein were isolated from TBEV-infected and mock-infected tick cells at days 2 and 6 p.i. and RNA-Seq and mass spectrometric technologies were used to identify changes in, respectively, transcript and protein abundance. Differential expression of transcripts was determined using the data analysis package DESeq resulting in a total of 43 statistically significantly differentially expressed transcripts in IDE8 cells and 83 in IRE/CTVM19 cells, while differential protein representation using Χ2 test statistics with Bonferroni correction in IDEG6 software resulted in 76 differentially represented proteins in IDE8 cells and 129 in IRE/CTVM19 cells. These included transcripts and proteins which could affect stages of the virus infection, including virus entry, replication, maturation and protein trafficking, and also innate immune responses such as phagocytosis, RNA interference (RNAi), the complement system, the ubiquitin-proteasome pathway, cell stress and the endoplasmic reticulum (ER) stress response. After verification of sequencing data by qRT-PCR, the ability of several of the identified transcripts or proteins to affect virus infection was determined by knockdown experiments in IDE8 and IRE/CTVM19 cells using wild type LGTV, LGTV replicons or TBEV replicons. Knockdown of genes encoding proteins including the ER chaperone gp96 and the heat-shock protein HSP90 resulted in increased virus production in both cell lines, hinting at an antiviral role. In contrast, knockdown of calreticulin, another ER chaperone, resulted in a decrease in virus production in IRE/CTVM19 cells but not in IDE8 cells, implying a requirement for virus production. This functional genomics approach has identified possible novel genes/proteins involved in the interaction between flaviviruses and tick cells and also revealed that there might be antiviral innate immune pathways present in ticks additional to the exogenous RNAi pathway.

Eastern Equine Encephalitis virus is a vector-borne virus amplified by the Culiseta melanura mosquito in an enzootic avian cycle, causing high morbidity and mortality to horses and humans when contracted as incidental hosts. The virus is distributed across most of the eastern United States, Canada, and Gulf coast, and has been expanding in geographic range and season of activity over time. Spatial-temporal trends in Cs. melanura abundance were correlated with available meteorological (temperature and precipitation) and remotely sensed environmental data for the period of 1997-2012 in Connecticut. The effects of inter-annual changes in precipitation, temperature, and groundwater levels on Cs. melanura abundances using time-series linear regression and cross-correlation analyses were inconclusive. Habitat modeling using logistic regression and landscape-based predictive variables demonstrated strong efficiency (46.2%) and acceptable sensitivity and specificity (65.6 and 78.6%, respectively) using NDVI difference and distance from palustrine areas as predictive factors. Remotely sensed data can improve the understanding of vector abundance patterns, helping to forecast future outbreaks and regional expansions by guiding surveillance efforts.

Acanthamoeba culbertsoni (A. culbertsoni) is an amphizoic amoeba that is the causative agent of Granulomatous Amoebic Encephalitis (GAE), an often fatal central nervous system infection that is seen most frequently in severely immunocompromised patients and is characterized by hemorrhagic and necrotic lesions of the brain as well as varying degrees of granuloma formation. A.culbertsoni isolates have also been identified in a few cases of Amoebic Keratitis, a painful, sight-threatening corneal infection that disproportionately affects contact lens users irrespective of immune status. Common features of both infections include amoebic interaction with host extracellular matrix (ECM) components as requisites for both attachment to, and subsequent invasion of, host tissues to facilitate disease establishment. Previous studies have demonstrated that pathogenic species of Acanthamoeba , such as A.culbertsoni, bind to the ECM proteins Laminin-1 and Collagen I to a greater extent than non-pathogenic species. It has also been documented in the literature that secreted Acanthamoeba proteases have the ability to degrade components of the extracellular matrix. The role of amoebic proteases in mediating the attachment and invasion processes is not entirely understood. Initial experiments conducted in the present study revealed secretion of approximately 150 and 55-kDa serine proteases during attachment as well as invasion of the ECM by A. culbertsoni. However, inhibition of these serine proteases using phenylmethylsulfonyl fluoride (PMSF) did not diminish the ability of amoebae to attach or invade. It was demonstrated that secretion of the observed proteases occurred in a constitutive rather than substrate-induced manner and that amoebae secrete these proteases under a number of different conditions. Additionally, a 140-kDa membrane-associated serine protease was identified which may prove to play a role in focal proteolytic degradation. Collectively, our results suggest that attachment to extracellular matrix components is mediated through non-protease-dependent mechanisms. We also suggest that ECM invasion by A.culbertsoni is predominately a mechanical process that may be supplemented or enhanced by focal proteolytic degradation of extracellular matrix components by membrane-associated proteases.

Obwohl eine wirksame Schutzimpfung verfügbar ist, sind Masern noch immer weltweit verbreitet. Mit etwa 750.000 Todesfällen jährlich gehören sie zu den gefährlichsten Infektionskrankheiten im Kindesalter überhaupt. Nicht allein wegen der masernvirusinduzierten Immunsuppression treten sekundäre bakterielle Infektionen, darunter Otitiden oder Pneumonien, gehäuft auf. Eine Beteiligung des zentralen Nervensystems kann zur akuten postinfektiösen Masernenzephalitis (APME), die meist mit einer hohen Defektheilungsrate einhergeht, oder zur letal verlaufenden subakuten sklerosierenden Panenzephalitis (SSPE) führen. Besonders gefürchtet sind die schweren Komplikationen der Riesenzellpneumonie oder der measles inclusion body encephalitis (MIBE) bei immunsupprimierten Patienten. Viele pathogenetische Aspekte und pathophysiologische Vorgänge sind dabei noch nicht gänzlich verstanden. Vaskuläre Endothelzellen sind neben Epithelzellen, Monozyten und Makrophagen sowie Lymphozyten als wichtige Zielzellen für das Masernvirus bei der Ausbreitung der Masernvirusinfektion und Entstehung ihrer Komplikationen anzusehen. In immunhistochemisch aufbereiteten pathologischen Schnittpräparaten wurden in infizierten und stark entzündlich veränderten Arealen immer wieder infizierte Gefäßendothelzellen gefunden. Eine systematische Untersuchung der Interaktion von Masernviren mit humanen Gefäßendothelzellen in vitro lag allerdings bislang nicht vor. Das Ziel dieser Dissertation war es nun, die Interaktion von attenuierten und virulenten Masernvirusstämmen mit humanen Gefäßendothelzellen grundlegend und systematisch zu untersuchen und eine Basis für die Definition pathogenetisch bedeutsamer molekularer Mechanismen zu schaffen. Hierfür wurde mit primären Endothelzellen der menschlichen Nabelschnurvene (HUVEC) und einer humanen mikrovaskulären Hirnendothelzelllinie (HBMEC) ein rein humanes Zellkulturmodell gewählt und unter Verwendung attenuierter und virulenter Masernvirusstämme den natürlichen Bedingungen Rechnung getragen. Als essentielle Grundlage für die Untersuchungsreihen wurden die Endothelzellen auf endothelzellspezifische Markermoleküle hin untersucht und charakterisiert. Einzig die Oberflächenproteine membrane cofactor protein (MCP oder CD46) und signaling lymphocytic activation molecule (SLAM oder CD150) sind bislang als zelluläre Rezeptoren für das Masernvirus identifiziert worden. Es konnte hier eindeutig nachgewiesen werden, dass HUVEC und HBMEC auf verschiedenen zellulären Ebenen konstitutiv CD46, nicht aber SLAM exprimieren. Weder eine Aktivierung der Endothelzellen mit diversen Zytokinen und Stimulantien, noch der Kontakt der Endothelzellen mit inaktivierten Masernviren vermochte eine Expression von SLAM zu induzieren, obwohl eine Expression von toll-like receptor 2 (TLR2) klar aufgezeigt werden konnte. Es konnte hier ebenfalls belegt werden, dass sowohl der attenuierte Masernvirusstamm Edmonston (Edm) als auch die virulenten Masernvirusstämme WTFb, Wü4797 und Wü5679 Endothelzellen infizieren und eine morphologische Zellalteration mit Ausbildung eines zytopathischen Effekts hervorrufen können. Weitere Analysen zeigten für Edm und Wü4797 ein enormes Infektionsausmaß und eine sehr gute Ausbreitungseffizienz, die durch die Anwesenheit CD46-spezifischer Antikörper nur bei Edm klar reduziert werden konnte. Eine Aktivierung der Endothelzellen mit diversen Zytokinen und Stimulantien trug keinen eindeutigen begünstigenden oder hemmenden Effekt auf die Masernvirusinfektion mit sich, Interferon-α und -γ schienen das Infektionsausmaß abzuschwächen. Folgeversuche zur Rezeptormodulation durch Masernviren deuten darauf hin, dass CD46 nur für den attenuierten Masernvirusstamm Edm, nicht aber für die virulenten Masernvirusstämme WTFb, Wü4797 und Wü5679 als zellulärer Rezeptor fungiert. Die Ergebnisse dieser Dissertation belegen eine von den beiden Masernvirusrezeptoren CD46 und SLAM unabhängige Infektion humaner vaskulärer Endothelzellen mit Masernviruswildtypstämmen. Diese Beobachtungen lassen einen weiteren, bislang noch nicht bekannten zellulären Rezeptor oder einen von einem zellulären Rezeptor unabhängigen Aufnahme- und Ausbreitungsmechanismus bei Gefäßendothelzellen vermuten. Es darf weiterhin als sicher angesehen werden, dass Endothelzellen in der Pathogenese von masernvirusinduzierten Komplikationen, sei es direkt oder indirekt, involviert sind. / Although an effective live vaccine is available, measles still represents a major infectious disease causing about 750,000 deaths a year, preferentially in children. Due to the measles virus (MV)-induced immunosuppression secondary bacterial infections as otitis or pneumonia are common complications. Neurological involvement can lead to the acute postinfectious measles encephalitis (APME), which usually ends up with severe cerebral damage, or to the lethal subacute sclerosing panencephalitis (SSPE). In particular, immunosuppressed patients may acquire serious complications such as giant-cell pneumonia or measles inclusion body encephalitis (MIBE). However, the pathogenesis of complicated measles is poorly understood. Apart from epithelial cells, monocytes, macrophages and lymphocytes vascular endothelial cells (EC) are supposed to be important target cells for MV and involved in the pathogenesis of classic and complicated measles. Immunohistochemistry of pathologic sections has repeatedly revealed infected vascular EC in areas of extensive infection and inflammation. A systematic in-vitro analysis of the interaction of MV with human vascular EC has not been performed yet. This dissertation issues now a basic and systematic investigation of the interaction of attenuated and virulent MV strains with human vascular EC and aims to create a basis to define molecular mechanisms of MV pathogenesis. Natural conditions were approached by using primary human umbilical vein endothelial cells (HUVEC) and a human brain microvascular endothelial cell line (HBMEC) as cell culture models and attenuated and virulent MV strains as infectious agents. As a prerequisite for all experiments, both the primary cells and the cell line were examined for their growth features and their expression of EC specific marker molecules. The surface proteins membrane cofactor protein (MCP or CD46) and signaling lymphocytic activation molecule (SLAM or CD150) have previously been described as cellular receptors for MV. It has been proven here that HUVEC and HBMEC express CD46 constitutively, whereas SLAM was not detectable on various cellular levels. Neither the activation of EC with a range of cytokines and stimulants nor the contact of EC with inactivated MV induced the expression of SLAM, although an expression of toll-like receptor 2 (TLR2) by EC can be observed. Several studies on the infection of EC with MV displayed that the attenuated MV strain Edmonston (Edm) and, to a lower extent, the virulent MV strains WTFb, Wü4797 and Wü5679 are able to infect EC, accompanied by morphologic alte¬rations and cytopathic effects. Further experiments revealed efficient replication and spreading especially of Edm and Wü4797 in EC cultures. However, CD46 specific antibodies were able to reduce the capability of Edm to infect EC clearly, the replication of Wü4797, however, was not affected. Activation of EC by preincubation with a range of cytokines or stimulants had no significant effect on MV infection, interferon-α and -γ seemed to lower the extent of MV infection. The following analyses of differential receptor modulation by MV indicate that CD46 acts as a cellular receptor only for the attenuated strain Edm, but not for the virulent strains WTFb, Wü4797 or Wü5679. The results of this dissertation provide clear evidence of a CD46- and SLAM-independent infection of human vascular EC with virulent MV strains. In consequence, a further, yet unidentified cellular receptor on EC or a receptor-independent uptake and spreading mechanism of MV in EC cultures must be postulated. Finally, it is certain that EC are involved in the pathogenesis of MV-induced complications, whether directly or indirectly.

A Artrite Encefalite Caprina (AEC) é uma lentivirose multisistêmica que tem a glândula mamária caprina como um dos alvos lesionais da doença. Pode causar uma manifestação mamária específica, chamada de mastite endurativa, além da mama representar uma importante via de eliminação do vírus, mesmo em animais que não apresentam a forma clínica. Considerando-se a possibilidade desta virose, cuja célula alvo predominante é o monócito, levar a alterações imunológicas que influenciem a susceptibilidade do animal a outras doenças, objetivou-se avaliar essa interação do vírus e da imunidade do hospedeiro por meio de fenotipagem, fagocitose e produção de Espécies reativas de oxigênio (ERO) e dos mecanismos de morte das células sanguíneas e lácteas de cabras naturalmente infectadas. Para isso 200 cabras foram triadas e, destas selecionadas oito fêmeas não sororreagentes e dez sororreagentes na pesquisa de anticorpos séricos para AEC, dentro dos padrões hematológicos da espécie e com dois exames bacteriológicos do leite negativos. O leite e o sangue colhido destes animais foram submetidos às seguintes provas: fenotipagem dos leucócitos CD4+, CD8+, CD14+, PG68A+ e CD45+, fagocitose de Staphylococcus aureus e de Escherichia coli por células CD14+ e PG68A+, produção de ERO e marcação com Anexina-V e Iodeto de Propídeo (PI) por granulócitos e células mononucleares. A infecção pelo VAEC pode ser associada a um aumento de células CD14+ no leite, mas não no sangue. Os outros perfis celulares não sofreram alterações. Quanto a função fagocítica, o vírus reduziu a porcentagem de fagocitose de Staphylococcus aureus por granulócitos PG68A+ do leite. Esta alteração não ocorreu na fagocitose de Escherichia coli e na produção de ERO dessas células, nem na fagocitose e produção de ERO pelas células CD14+ ressaltando que nesses processos a espécie bacteriana pode sofrer interações com o vírus ou mesmo com a resposta imune do organismo infectado. O VAEC não influenciou significativamente os mecanismos de morte ora investigados, mas a tendência dos resultados sugere que possa haver indução de morte por apoptose e/ou por necrose nos granulócitos do sangue e influenciar no processo de necrose destas células no leite, sem alterar esses processos nas células mononucleares. Ressalta-se a importância da interação monócito-neutrófilo na glândula mamária, principalmente nos animais sororreagentes para AEC, mesmo na ausência de mastite bacteriana. / The caprine arthritis encephalitis (CAE) is a multisystem lentivirose that have the goat mammary gland as one target of the lesional disease. May cause a mammary specific expression, called indurative mastitis, beyond these organ represent a major route of virus elimination, even in animals that do not exhibit this clinical manifestation. Considering the possibility of this virus, whose target cell are predominantly monocyte, lead to immunological changes that influence the animal\'s susceptibility to other diseases, this study aimed to evaluate the interaction of virus and host immunity by phenotyping, phagocytosis and production of reactive oxygen species (ROS) and the mechanisms of cell death, in blood and milk of goats naturally infected. For that, 200 goats were screened and was selected eight females non sero-reagents and ten seroreagents for serum antibodies against CAE, with the haematological analises within the species standards and two negative bacteriological tests of milk. Milk and blood from these animals underwent the following tests: phenotyping of leukocytes CD4+, CD8+, CD14+, PG68A+ and CD45+, phagocytosis of Staphylococcus aureus and Escherichia coli ROS production by CD14+ and PG68A+ cells, and labeling with Annexin-V and propidium iodide (PI) for granulocytes and mononuclear cells. CAEV infection may be associated with an increase in CD14+ cells in milk, but not in blood. The other cellular profile did not change. In the phagocytic function, the virus reduced the percentage of phagocytosis of Staphylococcus aureus by granulocytes PG68A+ milk. This change did not occur in the phagocytosis of Escherichia coli and production of ROS in these cells, nor in phagocytosis and ROS production by CD14+ cells, noting that in those cases the bacterial species may undergo interactions with the virus or even with the immune response of the infected organism. The VAEC not significantly affect the mechanism of death now investigated, but the tendency of the results suggests that can induce apoptosis and/or necrosis in the blood granulocytes and influence the process of necrosis of these cells in milk, without changing these processes mononuclear cells. We emphasize the importance of monocyte-neutrophil interaction in the mammary gland, especially in animals seropositive for CAE, even in the absence of bacterial mastitis.